Slow-Release Granisetron (APF530) Versus Palonosetron for Chemotherapy-Induced Nausea/Vomiting: Analysis by American Society of Clinical Oncology Emetogenicity Criteria

Single-dose APF530 is a promising alternative to palonosetron for preventing acute and delayed CINV after MEC or HEC. The Clinicaltrials.gov identifier for this study is NCT00343460.